Defining the COX inhibitor selectivity of NSAIDs: implications for understanding toxicity

@article{Knights2010DefiningTC,
  title={Defining the COX inhibitor selectivity of NSAIDs: implications for understanding toxicity},
  author={K. Knights and A. Mangoni and J. Miners},
  journal={Expert Review of Clinical Pharmacology},
  year={2010},
  volume={3},
  pages={769 - 776}
}
The hypothesis that the anti-inflammatory activity of NSAIDs derives from COX inhibition is well established. It also underpins the accepted mechanism of the gastrointestinal and renal toxicity of NSAIDs. However, in terms of NSAID-induced cardiovascular toxicity, is COX inhibition then guilty by association? Multiple experimental models of COX-1/COX-2 inhibition have enabled ranking of the relative inhibitory activity of NSAIDs. Inhibition is expressed as an IC50 value and the index of COX… Expand
Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications.
  • S. Harirforoosh, Waheed Asghar, F. Jamali
  • Medicine
  • Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques
  • 2013
TLDR
The GI toxicity of the NSAIDs is discussed, lower but still therapeutics doses of some NSAIDs may be cardioprotective and their renal and CV adverse effects are assessed. Expand
COX Inhibition Profile and Molecular Docking Studies of Some 2-(Trimethoxyphenyl)-Thiazoles
TLDR
The present data prove that the investigated compounds inhibit COX and thus confirm the previously reported in vivo anti-inflammatory screening results suggesting that A3 is a suitable candidate for further development as a NSAID. Expand
Prostanoid receptor EP2 as a therapeutic target.
  • T. Ganesh
  • Chemistry, Medicine
  • Journal of medicinal chemistry
  • 2014
TLDR
The PGE2 receptor EP2 is emerging as a pro-inflammatory target in a variety of CNS and peripheral diseases and future anti-inflammatory therapy could be targeted through a specific prostanoid receptor downstream of COX-2. Expand
Evaluation of Selective COX-2 Inhibition and In Silico Study of Kuwanon Derivatives Isolated from Morus alba
TLDR
Six kuwanon derivatives (A/B/C/E/H/J) extracted from the roots of Morus alba L. were evaluated to determine their cyclooxygenase (COX)-1 and 2 inhibitory effects, showing selective COX-2 inhibitory activity, almost equivalent to that of celecoxib, a known COX inhibitor. Expand
Discovery of new indomethacin-based analogs with potentially selective cyclooxygenase-2 inhibition and observed diminishing to PGE2 activities.
TLDR
New ring-extended analogs of indomethacin were designed based on the structure of active binding site of both COX-1 and COx-2 isoenzymes and the interaction pattern required for selective inhibition of COX -2 to improve its selectivity againstCOX-2 and were elaborated beyond the diarylsulfonamides. Expand
Clinical Pharmacology and Cardiovascular Safety of Naproxen
TLDR
The balance of evidence suggests that cardiovascular risk correlates with cyclooxygenase (COX)-2 selectivity, and the low COX-2Selectivity of naproxen results in a lower cardiovascular risk than that of other NSAIDs. Expand
NSAID induced gastrointestinal damage and designing GI-sparing NSAIDs
TLDR
This review is focused on damage caused by NSAIDs in the upper and lower GI tracts, the different mechanisms of damage and the GI-sparing NSAIDs designed to minimize adverse events based on understanding of these mechanisms. Expand
NSAIDs; Safety and Risk Assessment in CVS Events, Comparisons andFacts
TLDR
While cardiovascular toxicities associated with NSAIDs are mainly related with COX-2 selective inhibitor and primarily dependent on their dose time and duration, variability in therapeutic response and susceptibility to toxicity is well recognized and can be manageable if considerable precautions implement. Expand
Pharmacological evaluation of novel dimers of an arylpropionic acid class of non-selective cyclooxygenase inhibitors
Purpose : To explore and identify cyclooxygenase (COX) inhibitors with optimal potency and efficacy using an arylpropionic acid class of drugs as lead molecules. Methods : The selected lead moleculesExpand
Synthesis, inhibitory activity and in silico docking of dual COX/5-LOX inhibitors with quinone and resorcinol core.
TLDR
The most important structural modification leading to increased inhibitory activity towards both COXs and 5-LOX was the elongation of alkyl chain in position 6 from 5 to 11 carbons, which was identified as optimal alkyL chain length for dual COX/5- LOX inhibition. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 75 REFERENCES
Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities.
TLDR
Questions that remain to be addressed are whether this hazard extends to all or some of the traditional NSAIDs; whether adjuvant therapies, such as low-dose aspirin, will mitigate the hazard and if so, at what cost; whether COX-2 inhibitors result in cardiovascular risk transformation during chronic dosing; and how to identify individuals most likely to benefit or suffer from such drugs in the future. Expand
Cardiovascular effects of the cyclooxygenase inhibitors.
TLDR
The impact that the COX inhibitors have on CV events from several recent clinical trials for the treatment of arthritis or for cancer prevention, as well as from selected large observational studies, is discussed. Expand
Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic
  • T. Warner, Jane A. Mitchell
  • Medicine
  • FASEB journal : official publication of the Federation of American Societies for Experimental Biology
  • 2004
TLDR
Clinical use of COX‐2‐selective compounds has ignited strong debates regarding potential side effects, most notably those within the cardiovascular system such as myocardial infarctions, strokes, and elevation in blood pressure, and this review will discuss how the latest studies help to understand the roles ofCOX‐1 and COx‐2 and what clinically proven benefits the newer generation of CO X‐2•selective inhibitors offer. Expand
Experimental models used to investigate the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2 by non-steroidal anti-inflammatory drugs
TLDR
Analysis of the ratio of inhibition ofCOX-1 to COX-2 by non-steroidal anti-inflammatory drugs, suggests inhibitors can be classified based on their COX selectivity, and human pharmacology studies concentrating on the inhibition of prostanoid synthesis in target tissues are of paramount importance in determining the clinical relevance of COx-2 selectivity. Expand
Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2.
TLDR
The International Consensus Meeting on the Mode of Action of COX-2 Inhibition (ICMMAC) brought together 17 international experts in arthritis, gastroenterology and pharmacology to foster a consensus definition on COx-2 specificity and to consider the clinical relevance of COZ-2-specific agents. Expand
Evaluation of classical NSAIDs and COX-2 selective inhibitors on purified ovine enzymes and human whole blood.
TLDR
This study evaluated the COXs inhibitory profile of both conventional NSAIDs and COX-2 selective inhibitors using two different in vitro methods: the first test was performed using purified enzymes while the second method consisted of a whole blood assay. Expand
Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents
TLDR
The structures of unliganded murine COX-2 and complexes with flurbiprofen, indomethacin and SC-558, a selective COx-2 inhibitor, determined are explained and some of the conformational changes associated with time-dependent inhibition are demonstrated. Expand
Review: Adverse cardiovascular effects of NSAIDs: driven by blood pressure, or edema?
TLDR
The body of literature linking the nsNSAIDs and COX-2 inhibitors with important adverse cardiorenal effects and their putative mechanisms is reviewed. Expand
COX-2 selectivity alone does not define the cardiovascular risks associated with non-steroidal anti-inflammatory drugs
TLDR
Understanding of the assays and calculations underlying the production of data for COX selectivity suggests that great care needs to be taken in using in-vitro data to inform clinical use, and extrapolating ratios of selectivity to levels of COX-2 inhibition in vivo is of little benefi t—irrespective of their in-Vitro selectivities. Expand
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
TLDR
Characterization of the two COX isozymes is allowing the discrimination of the roles each play in physiological processes such as homeostatic maintenance of the gastrointestinal tract, renal function, blood clotting, embryonic implantation, parturition, pain, and fever. Expand
...
1
2
3
4
5
...